Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 7, 2008, Pages 2851-2858

  Van Hall, Gerrit ^a,b   Steensberg, Adam ^a,b   Fischer, Christian ^a,b   Keller, Charlotte ^a,b   Møller, Kirsten ^a,b   Moseley, Pope ^a   Pedersen, Bente K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; INTERLEUKIN 6; MUSCLE PROTEIN; PHENYLALANINE DERIVATIVE; RECOMBINANT INTERLEUKIN 6; SODIUM CHLORIDE; TRACE ELEMENT;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; DEGRADATION; FEMORAL ARTERY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; METHODOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; SKELETAL MUSCLE; SYNTHESIS; VASTUS MEDIALIS MUSCLE;

EID: 47549119091     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2223     Document Type: Article

References (35)

1. Pedersen BK, Steensberg A, Keller P, Keller C, Fischer C, Hiscock N, van Hall G, Plomgaard P, Febbraio MA 2003 Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects. Pflugers Arch 446:9-16
2. Wallenius V, Wallenius K, Ahrén B, Rudling M, Carlsten H, Dickson S, Ohlsson C, Jansson JO 2002 Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75-79
3. Coppack SW 2001 Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60:349-356
4. Frost RA, Lang CH 2005 Skeletal muscle cytokines: regulation by pathogen-associated molecules and catabolic hormones. Curr Opin Clin Nutr Metab Care 8:255-263
5. Warren R, Starnes H, Gabrilove J, Oettgen H, Brennan MF 1987 The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg 122:1396-1400
6. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK 2005 Tumor Necrosis Factor-α Induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54:2939-2945
7. Plomgaard P, Nielsen A, Fischer C, Mortensen O, Broholm C, Penkowa M, Krogh-Madsen R, Erikstrup C, Lindegaard B, Petersen A, Taudorf S, Pedersen B 2007 Associations between insulin resistance and TNF-α in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia 50:2562-2571
8. Vesali RF, Klaude M, Rooyackers O, Wernerman J 2005 Amino acid metabolism in leg muscle after an endotoxin injection in healthy volunteers. Am J Physiol Endocrinol Metab 288:E360-E364
9. Change TW, Goldberg AL 1978 The metabolic fate of amino acids and the formation of glutamine in skeletal muscle. J Biol Chem 253:3685-3693
10. Roth E, Funovics J, Muhlbacher F, Schemper M, Mauritz W, Sporn P, Fritsch A 1982 Metabolic disorders in severe abdominal sepsis: glutamine deficiency in skeletal muscle. Clin Nutr 1:25-41
11. Fischer C 2006 Interleukin-6 in acute exercise and training: what is the biological relevance. Exerc Immunol Rev 12:6-33
12. Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B, Pedersen BK 2001 Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 537(Pt 2):633-639
13. van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA, Pedersen BK 2003 Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88:3005-3010
14. Biolo G, Chinkes D, Zhang Z-J, Wolfe RR 1992 A new model to determine in vivo relationship between amino acid transmembrane transport and protein kinetics in muscle. JPEN J Parenter Enteral Nutr 16:305-315
15. Mittendorfer B, Volpi E, Wolfe RR 2001 Whole body and skeletal muscle glutamine metabolism in healthy subjects. Am J Physiol Endocrinol Metab 280:E323-E333
16. Kuhn KS, Schuhmann K, Stehle P, Darmaun D, Furst P 1999 Determination of glutamine in muscle protein facilitates accurate assessment of proteolysis and de novo synthesis-derived endogenous glutamine production. Am J Clin Nutr 70:484-489
17. Fong Y, Marano M, Moldawer L, Wei H, Valvano S, Kenney J, Allison A, Cerami A, Shires G, Lowry S 1990 The acute splanchnic and peripheral tissue metabolic responses to endotoxin in humans. J Clin Invest 85:1896-1904
18. Jepson M, Pell J, Bates P, Millward D 1986 The effects of endotoxemia on protein metabolism in skeletal muscle and liver of fed and fasted rats. Biochem J 235:329-336
19. Orellana RA, O'Connor PMJ, Nguyen HV, Bush JA, Suryawan A, Thivierge MC, Fiorotto ML, Davis TA 2002 Endotoxemia reduces skeletal muscle protein synthesis in neonates. Am J Physiol Endocrinol Metab 283:E909-E916
20. Darmaun D, Matthews DE, Bier DM 1988 Physiological hypercortisolemia increases proteolysis, glutamine, and alanine production. Am J Physiol 255(3 Pt 1):E366-E373
21. Goodman MN 1991 Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 260(5 Pt 1):E727-E730
22. Garciá-Martínez C, López-Soriano F, Argilés J 1994 Interleukin-6 does not activate protein breakdown in rat skeletal muscle. Cancer Lett 76:1-4
23. Williams A, Wang JJ, Wang L, Sun X, Fischer JE, Hasselgren PO 1998 Sepsis in mice stimulates muscle proteolysis in the absence of IL-6. Am J Physiol 275(6 Pt 2):R1983-R1991
24. Llovera M, Carbó N, López-Soriano J, García-Martínez C, Busquets S, Alvarez B, Agell N, Costelli P, López-Soriano FJ, Celada A, Argilés JM 1998 Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. Cancer Lett 133:83-87
25. Fujita J, Tsujinaka T, Ebisui C, Yano M, Shiozaki H, Katsume A, Ohsugi Y, Monden M 1996 Role of interleukin-6 in skeletal muscle protein breakdown and cathepsin activity in vivo. Eur Surg Res 28:361-366
26. Tsujinaka T, Ebisui C, Fujita J, Kishibuchi M, Morimoto T, Ogawa A, Katsume A, Ohsugi Y, Kominami E, Monden M 1995 Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem Biophys Res Commun 207:168-174
27. Tsujinaka T, Fujita J, Ebisui C, Yano M, Kominami E, Suzuki K, Tanaka K, Katsume A, Ohsugi Y, Shiozaki H, Monden M 1996 Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest 97:244-249
28. Volpi E, Kobayashi H, Sheffield-Moore M, Mittendorfer B, Wolfe RR 2003 Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. Am J Clin Nutr 78:250-258
29. Kobayashi H, Borsheim E, Anthony TG, Traber DL, Badalamenti J, Kimball SR, Jefferson LS, Wolfe RR 2003 Reduced amino acid availability inhibits muscle protein synthesis and decreases activity of initiation factor eIF2B. Am J Physiol Endocrinol Metab 284:E488-E498
30. Borsheim E, Kobayashi H, Traber DL, Wolfe RR 2006 Compartmental distribution of amino acids during hemodialysis-induced hypoaminoacidemia. Am J Physiol Endocrinol Metab 290:E643-E652
31. Raj DS, Dominic EA, Wolfe R, Shah VO, Bankhurst A, Zager PG, Ferrando A 2004 Coordinated increase in albumin, fibrinogen, and muscle protein synthesis during hemodialysis: role of cytokines. Am J Physiol Endocrinol Metab 286:E658-E664
32. Charters Y, Grimble RF 1989 Effect if recombinant human tumour necrosis factor a on protein synthesis in liver, skeletal muscle and skin of rats. Biochem J 258:493-497
33. Lang CH, Frost RA 2007 Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha. Metabolism 56:49-57
34. Llovera M, Lopez-Soriano FJ, Argiles JM 1993 Effects of tumor necrosis factor-α on muscle-protein turnover in female Wistar rats. J Natl Cancer Inst 85:1334-1339
35. Hoshino E, Pichard C, Greenwood CE, Kuo GC, Cameron RG, Kurian R, Kearns JP, Allard JP, Jeejeeboy KN 1991 Body composition and metabolic rate in rat during a continuous infusion of cachectin. Am J Physiol 260(1 Pt 1):E27-E36